Historique
Article de Périodique
Preliminary evidence of pregabalin misuse among prescription and/or illicit opioid (mis)users (2020)
Auteur(s) :
BUTTRAM, M. E. ;
KURTZ, S. P.
Année
2020
Page(s) :
172-175
Langue(s) :
Anglais
Domaine :
Autres substances / Other substances
Thésaurus géographique
ETATS-UNIS
Thésaurus mots-clés
PREGABALINE
;
OPIOIDES
;
ETUDE QUALITATIVE
;
ANTICONVULSIVANTS
;
MESUSAGE
;
USAGER
;
MOTIVATION
;
TYPE D'USAGE
;
EFFET RECHERCHE
Résumé :
Pregabalin is approved for the management of neuropathic pain, partial-onset seizures, and fibromyalgia. Although it is considered to have low potential for abuse, reports of misuse of pregabalin are emerging. The present study contributes to this literature by presenting preliminary evidence of pregabalin misuse. Mixed method interviews were conducted with prescription and/or illicit opioid (mis)users who reported a history of pregabalin misuse (N = 5). During semi-structured interviews, respondents provided descriptions of this practice, including motivation, route of administration, source, and drugs used/misused in combination with pregabalin. Motivations for pregabalin misuse included the self-treatment of physical pain (N = 1) and to achieve a desired psychoactive effect and/or combat opioid withdrawal symptoms (N = 4). Respondents described the misuse of pregabalin to potentiate the effects of heroin and cocaine, to feel "tipsy," and to experiment. We believe this report represents the first detailed contextual data about the misuse of pregabalin in the U.S. These misuse practices may represent an early indication of a growing problem. The recent permissibility of lower price generic versions has the potential to increase availability, decrease prices, and exacerbate pregabalin misuse.
Affiliation :
Center for Applied Research on Substance Use and Health Disparities, Nova Southeastern University, Miami, FL, USA
Cote :
Abonnement